Le Lézard
Classified in: Health
Subjects: ARTS/ENTERTAINMENT, HEALTH, LIFESTYLE, TRADE SHOWS/SEMINARS/WEBINARS, MISCELLANEOUS

Lift&Co. Expo Welcomes 10K+: Canada's No. 1 Cannabis & Psychedelics Conference is Back & Better Than Ever!


Toronto, ON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Exciting! Engaging! Enlightening! Lift&Co. Expo returned to Toronto last week, with exclamations aplenty. After an anticipation-building hiatus, Canada's no. 1 cannabis and psychedelics conference and trade show treated thousands to surprises and a-ha moments, levelling-up its signature experience with many forward-thinking new features.

Kicking off Day 1 on November 18, the event's fan-favourite full-day conference did not disappoint. The 2021 Lift Cannabis Business Conference gathered Canada's top business leaders, innovators, and policymakers for a veritable master class in the cannabis industry. Day 2 on November 19 brought the debut of the Lift Psychedelics Business Summit, an in-depth exploration of dynamic new psychedelics intel and advances. The Lift&Co. Expo Industry & Consumer Days trade show, November 19 ? 21, rounded out the schedule, including hundreds of up-and-coming exhibitors and dozens of special presentations.

Lift&Co. Expo 2021 Highlights included:

"This year's Lift&Co. Expo exceeded our expectations across the board," says Shawn Pierce, President of MCI Events. "As I walked the expo floor, talking with so many business owners and guests, I was inspired by the sense of camaraderie and positivity within the Lift&Co. community. It was a privilege to bring this beloved event back, and better than ever before. With thanks to the city of Toronto and the hard-working team members who made this show possible, we look forward to seeing you all again next year."

Save The Date!
Lift&Co. Expo
Toronto, Ontario
May 12-15, 2022

ABOUT MCI

MCI is the global leader in engaging and activating audiences. Our business is founded on a simple human insight:?When people come together, magic happens. Since 1987, we have been bringing people together through?inspiring meetings, events, congresses and associations or community management. MCI helps organizations harness the power of community by applying our strategic engagement and activation solutions to build unforgettable online and offline experiences that foster change, inspire, educate, and enhance business performance. MCI is an independently owned company headquartered in Geneva, Switzerland, and boasts a global presence with 2,500+ professionals in 61?offices and 31 countries, who work with clients across Europe, the Americas, Asia-Pacific, India, and the Middle East.?Visit us at?wearemci.com?or?Twitter,?LinkedIn,?Facebook.

ABOUT MVP EDUCATION, LLC  

MVP Education, LLC is an equity investor who partners with associations, event owners and license owners to accelerate the growth, innovation, and impact of your events.

Attachments



These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the...



News published on and distributed by: